Announcement PDF The 2026 Annual General Meeting of MyState Limited will be held on Tuesday, 20 October 2026 in Ballroom 2 at The Westin Brisbane, 111 Mary Street, Brisbane and online commencing at 10:30 a.m. AEST (local time) / 11:30 a.m. AEDT NOTICE OF Annual General Meeting 2026 3 Contents Board Chair’s Letter 4 Notice of Annual General Meeting 5 Items of Business 5 Explanatory Memorandum 9 Schedule 1 - Online Meeting Guide 14 Schedule 2 - Sample Proxy Form 16 Location of the 2026 Annual General Meeting 18 4 Dear Shareholder, On behalf of the Board of Directors (Board) of MyState Limited (MyState), I am pleased to invite you to participate in MyState’s annual general meeting (AGM) to be held in Brisbane on Tuesday, 20 October 2026 commencing at 10:30 a.m. AEST (local time) /11:30 a.m. AEDT. The Board has determined to hold a hybrid meeting again this year. This means shareholders will be able to attend the AGM in person in Ballroom 2 at The Westin Brisbane, 111 Mary Street, Brisbane or via an online platform. The online platform will enable shareholders to ask questions verbally or in writing regarding the business of the AGM and vote on the resolutions to be considered at the AGM. Alternatively, shareholders can ask questions prior to the AGM by emailing secretariat@mystatelimited.com.au and vote prior to the meeting by lodging a proxy online. In accordance with the Corporations Act 2001 (Cth), hard copies of the Notice of AGM will not be sent to shareholders, unless they have previously requested that they be provided with a hard copy of the Notice of AGM. Instead, the Notice of AGM and other related material, including an online meeting guide which provides detailed information on how to access and use the online platform, can be viewed and downloaded from our AGM website, which can be accessed at www.edocumentview.com.au/MYS2026. The Notice of AGM and accompanying documents following this letter should be read in their entirety. Voting before the AGM If you would like to vote but you are unable to participate in the AGM, you will need to appoint a proxy to vote on your behalf. You can appoint a proxy to vote on your behalf online via the abovementioned AGM website. If you require a hard copy proxy form, please contact our share registry, Computershare, by phone on 1300 538 803 (for calls within Australia) or +61 3 9415 4660 (for overseas calls). Participating in the AGM In addition to attending the meeting in person, shareholders are invited to participate in the meeting virtually via the online platform by entering the following URL into your web browser https://meetnow.global/MYS2026 and clicking ‘Join Meeting Now’. You will need to enter your shareholder details (including your SRN or HIN and postcode) so that you can be verified as a shareholder. Proxy holders will need to contact MyState’s share registry, Computershare, by phone on +61 3 9415 4024 to request their unique email invitation link prior to the meeting day so that they can participate in the AGM via the online platform. If you have appointed a proxy to virtually attend and vote at the AGM on your behalf, please ensure that you arrange for them to obtain their login details prior to the AGM. Through the online platform, shareholders (and proxy holders) will be able to listen to a live webcast of the AGM, ask questions regarding the business of the meeting and vote. A detailed guide on how to participate in the virtual AGM is set out in the Online Meeting Guide contained at Schedule 1 of the Notice of Meeting. I hope that you will join us at the AGM. Yours sincerely Vaughn Richtor Board Chair Board Chair’s Letter 18 September 2026 5 Items of Business ABN 26 133 623 962 Level 2, 137 Harrington Street, Hobart, Tasmania, 7000 Tel: 138 001 Fax: (03) 6215 9760 Notice of Annual General Meeting Notice is hereby given that the Annual General Meeting (AGM or Meeting) of the shareholders of MyState Limited (Company) will be held on Tuesday, 20 October 2026 in Ballroom 2 at The Westin Brisbane, 111 Mary Street, Brisbane and online commencing at 10:30 a.m. AEST (local time) / 11:30 a.m. AEDT. Shareholders or their proxy may participate in the AGM in person or via our online platform available at https://meetnow.global/MYS2026. Further information on how to participate in the AGM virtually or appoint a proxy is set out in this Notice of AGM. 1. Financial Statements and Reports (Item 1) To receive and consider the Financial Report, Directors’ Report and the Auditor’s Report for the year ended 30 June 2026 and provide shareholders with the opportunity to ask questions. 2. Re-election of Director – Warren Lee (Item 2) To consider and, if thought fit, pass the following resolution as an ordinary resolution: “THAT Warren Lee who retires from the office of Director in accordance with clause 62 of the Constitution and ASX Listing Rule 14.4, being eligible and offering himself for re-election, be re-elected as a Director of the Company.” 3. Re-election of Director – Andrea Waters (Item 3) To consider and, if thought fit, pass the following resolution as an ordinary resolution: “THAT Andrea Waters who retires from the office of Director in accordance with clause 62 of the Constitution and ASX Listing Rule 14.4, being eligible and offering herself for re-election, be re-elected as a Director of the Company.” 4. Remuneration Report (Item 4) To consider and, if thought fit, pass the following non-binding resolution as an ordinary resolution: “THAT, for the purposes of section 250R(2) of the Corporations Act and for all other purposes, the Remuneration Report (which forms part of the Directors’ Report) for the year ended 30 June 2026 be adopted.” Note: The vote on this resolution is advisory only. If 25% or more of votes that are cast on this resolution are voted against the adoption of the Remuneration Report at two (2) consecutive annual general meetings, shareholders will be required to vote at the second of those annual general meetings on a resolution (a‘spill resolution’) that another meeting be held within 90 days at which all of the Company’s Directors (other than a Managing Director) must be subject to re-election. Voting Exclusion Statement - Item 4 In accordance with sections 250BD and 250R of the Corporations Act, no vote may be cast by, and the Company will disregard any votes cast on this resolution by or on behalf of a member of the Company’s key management personnel (KMP), details of whose remuneration are included in the Remuneration Report, or a closely related party of any such member, whether as shareholder or proxy. However, in accordance with the Corporations Act, a person described above may vote on Item 4 if: • the vote is cast by such person as proxy for a person who is permitted to vote on the resolution, in accordance with the direction specified on the proxy form how to vote; or • the proxy is the Chair of the Meeting (Chair) and the appointment of the Chair as proxy does not specify the way the proxy is to vote on the resolution; • the appointment expressly authorises the Chair to exercise the proxy even if the resolution is connected directly or indirectly with the remuneration of a member of the KMP; and • the vote is not cast on behalf of a member of the KMP or a closely related party of a member of the KMP Shareholders who intend to appoint the Chair as their proxy (including an appointment by default) should have regard to the important information below under the heading“Important information concerning proxy votes on Items 4, and 5”. 6 Items of Business 5. Approval of the issue of performance rights to the Company’s Managing Director and Chief Executive Officer (Item 5) To consider and, if thought fit, pass the following resolution as an ordinary resolution: “THAT, for the purposes of ASX Listing Rule 10.14 and for all other purposes, the issue by the Company of up to 175,439 unlisted performance rights to the Company’s Managing Director and Chief Executive Officer (Mr Brett Morgan), as part of Mr Morgan’s remuneration for the financial year ended 30 June 2027 on the terms set out in the Explanatory Memorandum to this Notice of AGM, be approved.” Voting Exclusion Statement - Item 5 In accordance with the ASX Listing Rules, the Company will disregard any votes cast in favour of this resolution by or on behalf of Mr Brett Morgan, who is excluded from voting, or an associate of Mr Brett Morgan. However, this does not apply to a vote cast in favour of a resolution by: • a person as proxy or attorney for a person who is entitled to vote on the resolution, in accordance with the directions given to the proxy or attorney to vote on the resolution in that way; or • the Chair as proxy or attorney for a person who is entitled to vote on the resolution, in accordance with a direction given to the Chair to vote on the resolution as the Chair decides; or • a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met: - the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on the resolution; and - the holder votes on the resolution in accordance with directions given by the beneficiary to the holder to vote in that way. Further, in accordance with the Corporations Act, a vote must not be cast on this resolution (and will be taken not to have been cast if cast contrary to this restriction) by a member of the KMP, or any closely related party of such a member, acting as proxy, if their appointment does not specify the way the proxy is to vote on this resolution. However, the member or any closely related party of such a member may vote if they are Chair and the appointment expressly authorises the Chair to exercise the proxy even if the resolution is connected directly or indirectly with the remuneration of a member of the KMP. Shareholders who intend to appoint the Chair as their proxy (including an appointment by default) should have regard to the important information below under the heading“Important information concerning proxy votes on Items 4 and 5”. Explanatory memorandum Shareholders are referred to the Explanatory Memorandum accompanying and forming part of this Notice of AGM. Entitlement to Vote It has been determined that for the purposes of the Meeting, ordinary shares in the Company (Shares) will be taken to be held by the persons who are the registered shareholders of the Company at 7.00 p.m. (AEDT) on Sunday, 18 October 2026. Accordingly, share transfers registered after that time will be disregarded in determining entitlements to participate in and vote at the Meeting. Resolutions to be determined by Poll Voting on each item of business at the AGM will be conducted by poll. 7 Items of Business Voting by Proxy Sections 250BB and 250BC of the Corporations Act apply to voting by proxy. Shareholders and their proxies should be aware of the requirements under the Corporations Act, as they will apply to this Meeting. Broadly: • if proxy holders vote, they must cast all directed proxies as directed; and, • any directed proxies which are not voted will automatically default to the Chair, who must vote the proxies as directed. You should seek professional advice if you need any further information on this issue. In accordance with section 249L of the Corporations Act, shareholders are advised of the following: • A shareholder entitled to attend and vote at the Meeting has a right to appoint a proxy to attend and vote instead of the shareholder. A proxy need not be a shareholder and can be either an individual or a representative of a body corporate. • A proxy need not vote on a show of hands, however if a proxy does vote on a show of hands, the proxy must vote as directed. • A shareholder entitled to cast two or more votes at the Meeting may appoint two proxies and may specify the proportion or number of votes each proxy is appointed to exercise. If no proportion or number is specified, each proxy may exercise half of the shareholder’s votes. If a shareholder appoints two or more proxies that specify different ways to vote on a resolution, none of the proxies may vote on a show of hands. • If an appointed proxy is not also the Chair, the proxy need not vote on a poll, however if the proxy does vote on a poll the proxy must vote as directed by the shareholder. If a poll is conducted and the proxy holder does not vote, the proxy appointment defaults to the Chair to vote as directed. If the appointed proxy is the Chair, the proxy must vote on a poll in the manner directed by the shareholder. • Unless otherwise directed, the Chair intends to vote all proxies in favour of each resolution to be considered at the Meeting. Important information concerning proxy votes for Items 4 and 5 The Corporations Act places certain restrictions on the ability of key management personnel and their closely related parties to vote on the advisory resolution to adopt the Company’s remuneration report and resolutions connected directly or indirectly with the remuneration of the Company’s key management personnel. Key management personnel of the Company are the Directors of the Company and those other persons having authority and responsibility for planning, directing and controlling the activities of the Company, directly or indirectly. Members of key management personnel include Directors (both Executive and Non-Executive) and certain senior Executives. The Remuneration Report identifies the Company’s key management personnel for the financial year ended 30 June 2026. Their closely related parties are defined in the Corporations Act, and include certain members of their family, dependants and companies they control. For these reasons, shareholders who intend to vote by proxy should carefully consider the identity of their proxy and are encouraged to direct their proxy as to how to vote on all resolutions. In particular, shareholders who intend to appoint the Chair as their proxy (including an appointment by default) are encouraged to direct the Chair as to how to vote on all resolutions. If you do appoint the Chair as your proxy but you do not direct the Chair how to vote in respect of any or all of Items 4 and 5 the Chair will vote your undirected proxy in favour of each item. The appointment of the Chair as your proxy with any undirected voting instruction will be deemed to constitute an express authorisation by you directing the Chair to vote your proxy in favour of each of Items 4 and 5. This express authorisation acknowledges that the Chair will vote your proxy in favour of Items 4 and 5 even if he or she has an interest in the outcome of any of the resolutions and even if the items are connected directly or indirectly with remuneration of a member of the key management personnel of the Company and accordingly your votes will be counted in calculating the required majority if a poll is called. 8 Items of Business Lodging a Proxy All proxies must be received at least 48 hours before the appointed time of the Meeting. A sample Proxy Form is included at Schedule 2 for illustrative purposes, however, to appoint a proxy shareholders may: Lodge Online by visiting www.edocumentview.com.au/MYS2026 Lodge a paper proxy Please contact Computershare by phone to receive a personalised proxy form on 1300 538 803 (or +61 3 9415 4660 for overseas callers) and following completion lodge by: Post Computershare Investor Services Pty Limited GPO Box 242 Melbourne VIC 3001 Hand Computershare Investor Services Pty Limited 452 Johnston Street Abbotsford VIC 3067 Fax (within Australia) 1800 783 447 (outside Australia) +61 3 9473 2555 Custodian voting For Intermediary Online subscribers only (custodians) please visit www.intermediaryonline.com to submit your voting intentions. Voting By Attorney A shareholder may appoint an attorney to vote on their behalf. For an appointment to be effective for the Meeting, the instrument effecting the appointment (or a certified copy of it) must be received by the Company at its registered office or at the Company’s corporate registry listed above, at least 48 hours before the Meeting. Corporate Representatives A body corporate which is a shareholder, or which has been appointed as a proxy, may appoint an individual to act as its representative at the Meeting. The appointment must comply with the requirements of section 250D of the Corporations Act. The representative should bring to the Meeting evidence of their appointment, including any authority under which it is signed, unless it has previously been given to the Company. Scrutineer The Company’s external auditor, Ernst & Young will act as scrutineer for any polls that may be required at the Meeting. Questions from Shareholders Shareholders who are unable to participate in the Meeting or who may prefer to submit questions in advance of the Meeting are invited to do so. The deadline for receipt of questions is 5:00 p.m. (Hobart time) on Tuesday, 6 October 2026. During the Meeting the Chair will endeavour to address the themes most frequently raised prior to the Meeting. Please note that individual responses will not be sent to shareholders. Questions may be submitted as follows: By post  The Company Secretary MyState Limited Level 2, 137 Harrington Street Hobart Tasmania 7000 By email secretariat@mystatelimited.com.au An opportunity will be provided to ask questions in real time during the AGM via the online platform. Details on how to ask questions are provided in the Online Meeting Guide contained at Schedule 1 of this Notice of Meeting. By Order of the Board S Lukianenko Company Secretary 18 September 2026 9 Introduction This Explanatory Memorandum forms part of the Notice of AGM and has been prepared to provide shareholders with sufficient information to consider the resolutions to be put to the AGM of the Company which will be held as a hybrid meeting on Tuesday, 20 October 2026 commencing at 10:30 a.m. AEST / 11:30 a.m. AEDT. The Directors of the Company (Directors) recommend that shareholders read this Explanatory Memorandum carefully before making any decision in relation to the resolutions to be considered at the AGM. Financial Statements and Reports (Item 1) As required by section 317 of the Corporations Act, the Financial Statements, Directors’Report and Auditor’s Report of the Company for the financial year ended 30 June 2026 will be presented to the meeting. No vote of the shareholders is required on this item, and a resolution will not be put to the Meeting. Shareholders will be provided with the opportunity to ask questions or raise comments about the financial statements and reports or on the management of the Company via the online platform. Also, an opportunity will be given to shareholders to ask the Company’s external auditor questions relevant to the conduct of the audit, the preparation and content of the auditor’s report, the accounting policies adopted by the Company in relation to the preparation of the financial statements for the year ended 30 June 2026 and the independence of the auditor in relation to the conduct of the audit of those financial statements. Re-election of Directors (Items 2 & 3) Pursuant to ASX Listing Rule 14.4 and clause 62 of the Company’s constitution, Non-Executive Directors Warren Lee and Andrea Waters will retire at the AGM and being eligible, offer themselves for re-election. Directors Lee and Waters were each last elected in 2023. The Board considers each of Directors Lee and Waters to be independent. To be successfully elected, Directors Lee and Waters must each separately receive more votes‘For’than‘Against’. To support the orderly succession of the Board: • Director Lee intends to serve for three years and will retire at the conclusion of the 2029 AGM; and • Director Waters intends to serve for two years and will retire at the conclusion of the 2028 AGM. The experience, qualifications and other information about Directors Lee and Waters are as follows. Candidate Details Warren Lee Independent Non-Executive Director BCom, CA Director of MyState Bank Ltd, Chair of TPT Wealth Ltd Member of Group Risk Committee, Group Audit Committee Warren was appointed as a Non-Executive Director in October 2017 and appointed Chairman of TPT Wealth Limited on 17 August 2023. He has extensive experience in the international financial services industry, including 15 years at AXA in senior management positions within the company’s Australian and Asian businesses. Warren was previously the Chief Executive Officer of the Victorian Funds Management Corporation and Chief Executive Officer, Australia and New Zealand for AXA Asia Pacific Holdings Limited. He has previously served as a Director of Avenue Bank Limited and Tower Limited. Warren is currently a Non-Executive Director of MetLife Insurance Limited and Solterra Agriculture Pty Ltd. He is the Chair of both Rest Agriculture Pty Ltd and Warakirri Asset Management Limited. Andrea Waters Independent Non-Executive Director BCom, FCA, GAICD Director of MyState Bank Ltd, Director of TPT Wealth Ltd Chair of Group Audit Committee, Member of Group Risk Committee Andrea was appointed as a Non-Executive Director in October 2017. She is an experienced Non-Executive Director, auditor and accountant with over 40 years’ experience in financial services. She is a Fellow of Chartered Accountants Australia & New Zealand, and both a member and accredited facilitator of the Australian Institute of Company Directors. She is a former partner with KPMG, specialising in financial services audit. Andrea is the Chair of the Colonial Foundation and a Director of Helia Group Limited (ASX:HLI). Prior, she was previously the Chair of Grant Thornton Australia Ltd and a Director of The Lord Mayor’s Charitable Foundation, Chartered Accountants Australia & New Zealand, Bennelong Funds Management Group, Cancer Council Victoria, CareSuper, Citywide Service Solutions Pty Ltd and Cash Converters International Limited (ASX:CCV). Explanatory Memorandum 10 Remuneration Report (Item 4) Shareholders are asked to approve the adoption of the Company’s Remuneration Report. The Remuneration Report is included in the Directors Report contained in the Company’s 2026 Annual Report which is also available on the Company’s website at www.mystatelimited.com.au. The Remuneration Report sets out the remuneration arrangements of the Managing Director and Chief Executive Officer (MD & CEO) and specified senior Executives of the Company. The Corporations Act requires the agenda for an AGM to include a resolution that the Remuneration Report be put to the vote of shareholders. An opportunity for discussion of, and comment on, the Remuneration Report will be provided by the Chair at the AGM. Resolution Recommendation It is noted that each Director has a personal interest in his or her own remuneration from the Company as set out in the Remuneration Report. Notwithstanding this, the Board unanimously recommends that shareholders vote in favour of Item 4. Approval of the issue of performance rights to the Company’s Managing Director and Chief Executive Officer (Item 5) The Company seeks approval from its shareholders (Shareholders), for the purposes of ASX Listing Rule 10.14 and for all other purposes, for the issue of up to 175,439 performance rights (being an unlisted right to acquire one Share subject to the satisfaction of certain conditions) (Performance Right) to the Company’s Managing Director and Chief Executive Officer, Mr Morgan, under the Company’s Executive Long Term Incentive Plan (Plan) as part of his remuneration for the financial year ended 30 June 2027. As a Director, Mr Morgan is categorised as an ASX Listing Rule 10.14.1 related party. The number of Performance Rights to be issued to Mr Morgan was determined by dividing $800,000 (being 100% of Mr Morgan’s total fixed remuneration for FY27) by $4.56 being the volume weighted average price of the MyState Limited shares over the 20 trading days on ASX to 30 June 2026. A summary of the principal terms of the Performance Rights to be granted to Mr Morgan is set out below. Background At the 2023 AGM, approval was obtained from the Company’s shareholders for the issue to Mr Morgan up to 162,540 Performance Rights as part of his remuneration for the financial year ended 30 June 2024 for no consideration and at nil exercise price in accordance with the Plan. The 162,540 Performance Rights approved at the 2023 AGM were issued to Mr Morgan on 31 October 2023 on the terms as approved. At the 2024 AGM approval was obtained from the Company’s shareholders for the issue to Mr Morgan up to 136,170 Performance Rights as part of his remuneration for the financial year ended 30 June 2025 for no consideration and at nil exercise price in accordance with the Plan. The 136,170 Performance Rights approved at the 2024 AGM were issued to Mr Morgan on 30 October 2024 on the terms as approved. At the 2025 AGM approval was obtained from the Company’s shareholders for the issue to Mr Morgan up to 168,075 Performance Rights as part of his remuneration for the financial year ended 30 June 2026 for no consideration and at nil exercise price in accordance with the Plan. The 168,075 Performance Rights approved at the 2025 AGM were issued to Mr Morgan on 22 October 2025 on the terms as approved. Mr Morgan has again been invited by the Board, and is entitled, to participate in the Plan and to be issued with Performance Rights as part of his long term incentive if approved by shareholders at this AGM. The Board has set Mr Morgan’s remuneration package for FY27 to include the grant of Performance Rights under the Plan contingent upon the achievement of performance goals aligned with the continued growth of the MyState business and creation of Shareholder value. The Board has also reviewed the overall alignment of Mr Morgan’s and other key Executives’long term incentives. The Board aims to consistently align the remuneration of all Executives participating in the Company’s long term incentive arrangements with similar terms and performance measures which are reviewed annually. The Company’s Remuneration Policy is also available at www.mystatelimited.com.au. Explanatory Memorandum 11 Requirements under the ASX Listing Rules ASX Listing Rule 10.14 provides that a company may not issue securities to a Director under an employee incentive scheme without the approval of holders of ordinary shares. If Shareholder approval is obtained under ASX Listing Rule 10.14, the issue of the Performance Rights to Mr Morgan will not count towards the Company’s capacity to issue equity securities under ASX Listing Rule 7.1. Accordingly, Shareholder approval is sought for the issue of up to 175,439 Performance Rights as part of Mr Morgan’s FY27 remuneration under the Plan. In accordance with the requirements of ASX Listing Rule 10.15, the following information is provided in respect of the proposed issue of the FY27 Performance Rights to Mr Morgan. Name of the person receiving the securities and the category in ASX Listing Rules 10.14.1 – 10.14.3 the person falls within and why The FY27 Performance Rights the subject of this Item 5 will be issued to Mr Morgan, who is a Director. The number and class of securities proposed to be issued to Mr Morgan under the Plan for which approval is being sought under ASX Listing Rule 10.14 The maximum number of Performance Rights to be issued to Mr Morgan pursuant to this Item 5 is 175,439 (which on vesting will entitle Mr Morgan to be issued a maximum of 175,439 Shares). Details of Mr Morgan’s current total remuneration package Mr Morgan’s current remuneration package for FY27 comprises $800,000 as total fixed remuneration (inclusive of superannuation) and up to $720,000 as the maximum amount he can earn as variable, short term incentive remuneration. Mr Morgan is also entitled to the Performance Rights which are the subject of this Item 5. Shareholders are referred to the Company’s current Remuneration Report for further details of Mr Morgan’s remuneration. The date or dates on or by which the Company will issue the Performance Rights to Mr Morgan If Shareholder approval is obtained for the issue of the Performance Rights the subject of this Item 5, the FY27 Performance Rights will be granted to Mr Morgan within 3 years of Shareholder approval being obtained. The number of securities that have previously been issued to Mr Morgan under the Plan and the average acquisition price (if any) paid by Mr Morgan for those securities Since Mr Morgan’s employment commenced with the Company in January 2022 the Company has issued the following Performance Rights: • 146,119 Performance Rights were issued to Mr Morgan on the terms as approved at the 2022 AGM, • 162,540 Performance Rights were issued to Mr Morgan on the terms as approved at the 2023 AGM, • 136,170 Performance Rights were issued to Mr Morgan on the terms as approved at the 2024 AGM, and • 168,075 Performance Rights were issued to Mr Morgan on the terms as approved at the 2025 AGM. Mr Morgan did not pay any acquisition price to acquire these Performance Rights. The Company has not issued any Shares to Mr Morgan under the Plan. Details required where the securities to be issued are not fully paid ordinary securities A summary of the material terms upon which the Performance Rights will be issued is set out below under the headings‘Summary of the terms which apply to the issue of FY27 Performance Rights to be issued to Mr Morgan’. The price at which the Company will issue the FY27 Performance Rights to Mr Morgan under the Plan No consideration will be payable by Mr Morgan to acquire the Performance Rights or to acquire Shares on vesting and exercise of the FY27 Performance Rights. A summary of the material terms of any loan that will be made to Mr Morgan in connection with the issue of